Literature DB >> 23505617

Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010.

Mohammad H Forouzanfar1, Andrew E Moran, Abraham D Flaxman, Gregory Roth, George A Mensah, Majid Ezzati, Mohsen Naghavi, Christopher J L Murray.   

Abstract

BACKGROUND: Ischemic Heart Disease (IHD) is the leading cause of death worldwide. The Global Burden of Diseases, Injuries and Risk Factors (GBD) 2010 Study estimated IHD mortality and disability burden for 21 world regions for the years 1990 to 2010.
METHODS: Data sources for GBD IHD epidemiology estimates were mortality surveillance, verbal autopsy, and vital registration data (for IHD mortality) and systematic review of IHD epidemiology literature published 1980-2008 (for non-fatal IHD outcomes). An estimation and validation process led to an ensemble model of IHD mortality by country for all 21 world regions, adjusted for country-level covariates. Disease models were developed for the nonfatal sequelae of IHD: myocardial infarction, stable angina pectoris, and ischemic heart failure.
RESULTS: Country level covariates including metabolic and nutritional risk factors, education, war, and annual income per capita contributed to the ensemble model for the analysis of IHD death. In the acute myocardial infarction model, inclusion of troponin in the diagnostic criteria of studies published after the year 2000 was associated with a 50% higher incidence. Self-reported diagnosis of angina significantly overestimated stable angina prevalence compared with "definite" angina elicited by the Rose angina questionnaire. For 2010, Eastern Europe and Central Asia had the highest rates of IHD death and the Asia Pacific High-Income, East Asia, Latin American Andean, and sub-Saharan Africa regions had the lowest.
CONCLUSIONS: Global and regional IHD epidemiology estimates are needed for estimating the worldwide burden of IHD. Using descriptive meta-analysis tools, the GBD 2010 standardized and pooled international data by adjusting for region-level mortality and risk factor data, and study level diagnostic method. Analyses maximized internal consistency, generalizability, and adjustment for known sources of bias. The GBD IHD analysis nonetheless highlights the need for improved IHD epidemiology surveillance in many regions and the need for uniform diagnostic standards.

Entities:  

Year:  2012        PMID: 23505617      PMCID: PMC3595103          DOI: 10.1016/j.gheart.2012.10.003

Source DB:  PubMed          Journal:  Glob Heart


  47 in total

Review 1.  Cereals, legumes, and chronic disease risk reduction: evidence from epidemiologic studies.

Authors:  L H Kushi; K A Meyer; D R Jacobs
Journal:  Am J Clin Nutr       Date:  1999-09       Impact factor: 7.045

2.  It's time for a change to a troponin standard.

Authors:  A S Jaffe; J Ravkilde; R Roberts; U Naslund; F S Apple; M Galvani; H Katus
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

3.  Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute.

Authors:  Russell V Luepker; Fred S Apple; Robert H Christenson; Richard S Crow; Stephen P Fortmann; David Goff; Robert J Goldberg; Mary M Hand; Allan S Jaffe; Desmond G Julian; Daniel Levy; Teri Manolio; Shanthi Mendis; George Mensah; Andrzej Pajak; Ronald J Prineas; K Srinath Reddy; Veronique L Roger; Wayne D Rosamond; Eyal Shahar; A Richey Sharrett; Paul Sorlie; Hugh Tunstall-Pedoe
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

Review 4.  Biomarkers in acute cardiac disease: the present and the future.

Authors:  Allan S Jaffe; Luciano Babuin; Fred S Apple
Journal:  J Am Coll Cardiol       Date:  2006-06-12       Impact factor: 24.094

5.  Performance of physician-certified verbal autopsies: multisite validation study using clinical diagnostic gold standards.

Authors:  Rafael Lozano; Alan D Lopez; Charles Atkinson; Mohsen Naghavi; Abraham D Flaxman; Christopher Jl Murray
Journal:  Popul Health Metr       Date:  2011-08-04

6.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

7.  Algorithms for enhancing public health utility of national causes-of-death data.

Authors:  Mohsen Naghavi; Susanna Makela; Kyle Foreman; Janaki O'Brien; Farshad Pourmalek; Rafael Lozano
Journal:  Popul Health Metr       Date:  2010-05-10

8.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

9.  Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets.

Authors:  Christopher Jl Murray; Alan D Lopez; Robert Black; Ramesh Ahuja; Said Mohd Ali; Abdullah Baqui; Lalit Dandona; Emily Dantzer; Vinita Das; Usha Dhingra; Arup Dutta; Wafaie Fawzi; Abraham D Flaxman; Sara Gómez; Bernardo Hernández; Rohina Joshi; Henry Kalter; Aarti Kumar; Vishwajeet Kumar; Rafael Lozano; Marilla Lucero; Saurabh Mehta; Bruce Neal; Summer Lockett Ohno; Rajendra Prasad; Devarsetty Praveen; Zul Premji; Dolores Ramírez-Villalobos; Hazel Remolador; Ian Riley; Minerva Romero; Mwanaidi Said; Diozele Sanvictores; Sunil Sazawal; Veronica Tallo
Journal:  Popul Health Metr       Date:  2011-08-04

10.  Alcohol consumption and increased mortality in Russian men and women: a cohort study based on the mortality of relatives.

Authors:  Amanda Nicholson; Martin Bobak; Michael Murphy; Richard Rose; Michael Marmot
Journal:  Bull World Health Organ       Date:  2005-11-10       Impact factor: 9.408

View more
  43 in total

1.  Economic impact assessment from the use of a mobile app for the self-management of heart diseases by patients with heart failure in a Spanish region.

Authors:  José Antonio Cano Martín; Borja Martínez-Pérez; Isabel de la Torre-Díez; Miguel López-Coronado
Journal:  J Med Syst       Date:  2014-07-04       Impact factor: 4.460

2.  Glycyrrhetinic acid protects H9c2 cells from oxygen glucose deprivation-induced injury through the PI3K/AKt signaling pathway.

Authors:  Liqin Wang; Yuyan Zhang; Haitong Wan; Weifeng Jin; Li Yu; Huifen Zhou; Jiehong Yang
Journal:  J Nat Med       Date:  2016-07-12       Impact factor: 2.343

3.  Increasing the Efficacy of Stem Cell Therapy via Triple-Function Inorganic Nanoparticles.

Authors:  Fang Chen; Eric Ruike Zhao; Ghanim Hableel; Tao Hu; Taeho Kim; Jingting Li; Natalia Isabel Gonzalez-Pech; David J Cheng; Jeanne E Lemaster; Yijun Xie; Vicki H Grassian; George L Sen; Jesse V Jokerst
Journal:  ACS Nano       Date:  2019-06-17       Impact factor: 15.881

4.  Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.

Authors:  Peter Ueda; Mark Woodward; Yuan Lu; Kaveh Hajifathalian; Rihab Al-Wotayan; Carlos A Aguilar-Salinas; Alireza Ahmadvand; Fereidoun Azizi; James Bentham; Renata Cifkova; Mariachiara Di Cesare; Louise Eriksen; Farshad Farzadfar; Trevor S Ferguson; Nayu Ikeda; Davood Khalili; Young-Ho Khang; Vera Lanska; Luz León-Muñoz; Dianna J Magliano; Paula Margozzini; Kelias P Msyamboza; Gerald Mutungi; Kyungwon Oh; Sophal Oum; Fernando Rodríguez-Artalejo; Rosalba Rojas-Martinez; Gonzalo Valdivia; Rainford Wilks; Jonathan E Shaw; Gretchen A Stevens; Janne S Tolstrup; Bin Zhou; Joshua A Salomon; Majid Ezzati; Goodarz Danaei
Journal:  Lancet Diabetes Endocrinol       Date:  2017-01-24       Impact factor: 32.069

Review 5.  Burden of cardiovascular morbidity and mortality following humanitarian emergencies: a systematic literature review.

Authors:  Kaitlin G Hayman; Davina Sharma; Robert D Wardlow; Sonal Singh
Journal:  Prehosp Disaster Med       Date:  2014-12-15       Impact factor: 2.040

6.  Cardiac regeneration in model organisms.

Authors:  Laurent Gamba; Michael Harrison; Ching-Ling Lien
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-03

7.  The epidemiology of cardiovascular diseases in sub-Saharan Africa: the Global Burden of Diseases, Injuries and Risk Factors 2010 Study.

Authors:  Andrew Moran; Mohammad Forouzanfar; Uchechukwu Sampson; Sumeet Chugh; Valery Feigin; George Mensah
Journal:  Prog Cardiovasc Dis       Date:  2013-09-28       Impact factor: 8.194

Review 8.  The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study.

Authors:  Andrew E Moran; Mohammad H Forouzanfar; Gregory A Roth; George A Mensah; Majid Ezzati; Abraham Flaxman; Christopher J L Murray; Mohsen Naghavi
Journal:  Circulation       Date:  2014-02-26       Impact factor: 29.690

Review 9.  Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study.

Authors:  Andrew E Moran; Mohammad H Forouzanfar; Gregory A Roth; George A Mensah; Majid Ezzati; Christopher J L Murray; Mohsen Naghavi
Journal:  Circulation       Date:  2014-02-26       Impact factor: 29.690

10.  Variations in ischemic heart disease burden by age, country, and income: the Global Burden of Diseases, Injuries, and Risk Factors 2010 study.

Authors:  Andrew E Moran; Keane Y Tzong; Mohammad H Forouzanfar; Gregory A Rothy; George A Mensah; Majid Ezzati; Christopher J L Murray; Mohsen Naghavi
Journal:  Glob Heart       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.